Integral Diagnostics Statistics

Total Valuation

Integral Diagnostics has a market cap or net worth of AUD 687.71 million. The enterprise value is 1.00 billion.

Market Cap	687.71M
Enterprise Value	1.00B

Important Dates

The last earnings date was Wednesday, November 20, 2024.

Earnings Date	Nov 20, 2024
Ex-Dividend Date	Aug 30, 2024

Share Statistics

Integral Diagnostics has 233.92 million shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class	n/a
Shares Outstanding	233.92M
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	+2.64%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	49.58%
Float	210.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	28.32
PS Ratio	1.46
PB Ratio	2.28
P/TBV Ratio	n/a
P/FCF Ratio	16.27
P/OCF Ratio	n/a
PEG Ratio	0.72

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.27, with an EV/FCF ratio of 23.72.

EV / Earnings	-16.53
EV / Sales	2.14
EV / EBITDA	11.27
EV / EBIT	23.82
EV / FCF	23.72

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.19.

Current Ratio	0.87
Quick Ratio	0.81
Debt / Equity	1.19
Debt / EBITDA	4.02
Debt / FCF	8.46
Interest Coverage	1.89

Financial Efficiency

Return on equity (ROE) is -17.99% and return on invested capital (ROIC) is 3.77%.

Return on Equity (ROE)	-17.99%
Return on Assets (ROA)	3.36%
Return on Capital (ROIC)	3.77%
Revenue Per Employee	237,581
Profits Per Employee	-30,703
Employee Count	1,977
Asset Turnover	0.60
Inventory Turnover	181.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.93% in the last 52 weeks. The beta is 0.73, so Integral Diagnostics's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+71.93%
50-Day Moving Average	3.03
200-Day Moving Average	2.62
Relative Strength Index (RSI)	48.87
Average Volume (20 Days)	448,073

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Integral Diagnostics had revenue of AUD 469.70 million and -60.70 million in losses. Loss per share was -0.26.

Revenue	469.70M
Gross Profit	151.90M
Operating Income	42.17M
Pretax Income	-57.14M
Net Income	-60.70M
EBITDA	71.55M
EBIT	42.17M
Loss Per Share	-0.26

Full Income Statement

Balance Sheet

The company has 42.44 million in cash and 357.80 million in debt, giving a net cash position of -315.36 million or -1.35 per share.

Cash & Cash Equivalents	42.44M
Total Debt	357.80M
Net Cash	-315.36M
Net Cash Per Share	-1.35
Equity (Book Value)	301.71M
Book Value Per Share	1.29
Working Capital	-10.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 66.16 million and capital expenditures -23.88 million, giving a free cash flow of 42.28 million.

Operating Cash Flow	66.16M
Capital Expenditures	-23.88M
Free Cash Flow	42.28M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 32.34%, with operating and profit margins of 8.98% and -12.92%.

Gross Margin	32.34%
Operating Margin	8.98%
Pretax Margin	-12.16%
Profit Margin	-12.92%
EBITDA Margin	15.23%
EBIT Margin	8.98%
FCF Margin	9.00%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.04%.

Dividend Per Share	0.06
Dividend Yield	2.04%
Dividend Growth (YoY)	-3.33%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.23%
Shareholder Yield	1.81%
Earnings Yield	-8.84%
FCF Yield	6.15%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Integral Diagnostics has an Altman Z-Score of 1.53. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.53
Piotroski F-Score	n/a